Quest Diagnostics (DGX) analyst forecast and price target
Analyst forecast
Consensus of 20 analyst ratings
Based on 6 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| JP Morgan | Maintained | Neutral | $250.00 from $220.00 | Jul 28, 2026 |
| Baird | Maintained | Neutral | $255.00 from $236.00 | Jul 24, 2026 |
| Barclays | Maintained | Overweight | $250.00 from $230.00 | Jul 24, 2026 |
| Truist Securities | Maintained | Hold | $250.00 from $225.00 | Jul 24, 2026 |
| Mizuho | Maintained | Outperform | $260.00 from $235.00 | Jul 24, 2026 |
| UBS | Maintained | Neutral | $232.00 from $220.00 | Jul 24, 2026 |
| Baird | Maintained | Neutral | $236.00 from $232.00 | Jul 13, 2026 |
| Truist Securities | Maintained | Hold | $225.00 from $220.00 | Apr 22, 2026 |
| Barclays | Maintained | Overweight | $230.00 from $225.00 | Apr 22, 2026 |
| Baird | Maintained | Neutral | $229.00 from $224.00 | Apr 22, 2026 |
| UBS | Maintained | Neutral | $220.00 from $210.00 | Apr 22, 2026 |
| Evercore ISI Group | Maintained | In-Line | $210.00 from $220.00 | Apr 8, 2026 |
| Mizuho | Maintained | Outperform | $235.00 from $210.00 | Feb 12, 2026 |
| Jefferies | Maintained | Buy | $220.00 from $215.00 | Feb 11, 2026 |
| Evercore ISI Group | Maintained | In-Line | $220.00 from $190.00 | Feb 11, 2026 |
| Barclays | Maintained | Overweight | $225.00 from $210.00 | Feb 11, 2026 |
| UBS | Maintained | Neutral | $210.00 from $190.00 | Feb 11, 2026 |
| Truist Securities | Maintained | Hold | $220.00 from $205.00 | Feb 11, 2026 |
| Citigroup | Maintained | Neutral | $215.00 from $190.00 | Feb 10, 2026 |
| Piper Sandler | Maintained | Neutral | $200.00 from $190.00 | Oct 27, 2025 |
Frequently asked questions
What is the price target for DGX stock?
The average 12-month analyst price target for Quest Diagnostics (DGX) is $249.50, with a high estimate of $260.00 and a low of $232.00, across 6 analysts.
Is DGX a buy, sell, or hold?
Analysts covering Quest Diagnostics currently average a Hold rating: 9 buy, 10 hold and 1 sell, from 20 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for DGX?
The average price target of $249.50 implies 3.83% upside from the last price of $240.30.
What is the latest analyst rating on DGX?
On Jul 28, 2026, JP Morgan maintained Quest Diagnostics at Neutral with a price target of $250.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.